ストックスクリーナーアプリを入手
6.745
6.58%
-0.475
アフターアワーズ：
6.87
0.125
+1.85%
Journey Medical Corp (DERM) 最新ニュース
Journey Medical Corp focuses on dermatology growth. DERM stock reflects a specialized niche strategy - AD HOC NEWS
Form 4 Journey Medical Corp For: 2 July By Investing.com - Investing.com Canada
DERM Stock Price, Quote & Chart - ChartMill
Form 4 Journey Medical Corp For: 26 June By Investing.com - Investing.com Nigeria
Director at Journey Medical (DERM) receives 10,000 restricted stock units - Stock Titan
Journey Medical (DERM) director awarded 10,000 restricted stock units in equity grant - Stock Titan
Journey Medical (DERM) director receives 10,000 RSUs vesting in 2027 - Stock Titan
Journey Medical (DERM) director granted 10,000 RSUs, holds over 397K shares - Stock Titan
Merck KGaA (MKKGY) Soars 5.3%: Is Further Upside Left in the Stock? - Yahoo! Finance Canada
Journey Medical Corporation (DERM) Files Form 8-K with SEC – Key Company Details and Filing Information (June 24, 2026) – Minichart - Minichart
Journey Medical Shareholders Back Board and Auditor Slate - TipRanks
Journey Medical (DERM) 2026 meeting backs all directors and re-approves KPMG - Stock Titan
Journey Medical Corp. Actuals & Estimates (NASDAQ:DERM) - TradingView
Journey Medical (DERM) Stock Draws Fresh Price Target Split After Fortress Valuation Changes - Yahoo Finance
Journey Medical Corp (DERM) Institutional Confidence - TradingKey
Best Travel Insurance Companies For 2026: Expert-Rated - Forbes
Journey Medical Corp (DERM) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Fortress Biotech (NASDAQ: FBIO) reports 2026 director and auditor vote tallies - Stock Titan
Best travel insurance if you have a medical condition 2026 - which.co.uk
AI lab Midjourney investing over $74M to launch whole-body ultrasound screening business - Radiology Business
Journey Medical Corp (DERM) Valuation: PE, PB & Fair Value Analysis - TradingKey
Journey Medical Corp (DERM) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Journey Medical Corp (DERM) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Journey Medical Corp (DERM) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Journey Medical Corp (DERM) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Journey Medical Corp (DERM) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Journey Medical Corp (DERM) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Clínica de Especialidades Oftalmológicas (CEO) Becomes First Organization in the World Accredited Under GHA Healthcare Organization Standards 1.0 and GHA Integrated Accreditation for Medical Travel - Morningstar
Este Medical Group Announces Enhanced Consultation and Aftercare Pathway for International Hair Transplant Patients - Digital Journal
How The Journey Medical (DERM) Investment Narrative Is Evolving With An Unchanged Valuation Target - Yahoo Finance
Journey Medical Shares Drop—DERM’s 2026 Outlook Hinges on Emrosi Trial - Bez Kabli
10 Best Travel Insurance Companies For 2026 - Forbes
Journey Medical Corp stock (US48113J1007): calm start to the week after recent gains - AD HOC NEWS
Medical AI Market Size & Share | Industry Report, 2026-2033 - Grand View Research
MediWound (MDWD) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance
Earnings call transcript: Journey Medical Q1 2026 shows 21% revenue rise - Investing.com
Journey Medical Analyst Ratings and Price Targets | NASDAQ:DERM - Benzinga
Analysts Offer Insights on Healthcare Companies: Plus Therapeutics (PSTV) and Iridex (IRIX) - The Globe and Mail
Journey Medical CEO to join A.G.P. Virtual Healthcare Conference fireside chat on May 20, 2026 - Pluang
Journey Medical Corporation to Participate in A.G.P.’s Annual Virtual Healthcare Conference - The Manila Times
Journey Medical CEO to join online talk at A.G.P. health event - Stock Titan
Journey Medical Corp stock (US48113J1007): dermatology player in focus after recent financing update - AD HOC NEWS
Analysts Offer Insights on Healthcare Companies: RenovoRx (RNXT), Neurogene (NGNE) and ARS Pharmaceuticals (SPRY) - The Globe and Mail
Journey Medical Corporation (NASDAQ:DERM) Q1 2026 Earnings Call Transcript - Insider Monkey
Lake Street Sticks to Its Buy Rating for Journey Medical Corp (DERM) - The Globe and Mail
Journey Medical Corporation Q1 2026 Earnings Call Summary - Yahoo Finance
Analyst Reiterates Buy on Journey Medical, Maintains $13 Price Target After Strong 1Q26 and Emrosi Momentum - TipRanks
Journey Medical Corp stock (US48113J1007): Q1 revenue jumps 21% to $16M - AD HOC NEWS
Journey Medical Corp (DERM) Q1 2026 Earnings Call Highlights: Revenue Growth and Strategic ... By GuruFocus - Investing.com Canada
Here's What Key Metrics Tell Us About Journey Medical (DERM) Q1 Earnings - Yahoo Finance
Earnings call transcript: Journey Medical Q1 2026 reports strong EPS beat - Investing.com
Journey Medical Corp reports results for the quarter ended March 31Earnings Summary - TradingView
Earnings call transcript: Journey Medical Q1 2026 shows strong revenue growth - Investing.com
Transcript: Journey Medical Q1 2026 Earnings Conference Call - Benzinga
Journey Medical Corporation (DERM) Reports Q1 Loss, Beats Revenue Estimates - Yahoo Finance
Journey Medical earnings beat by $0.05, revenue fell short of estimates - Investing.com
Journey Medical Corp (NASDAQ:DERM) Slightly Misses Q1 2026 Revenue Expectations as Stock Rises on Strong Emrosi Growth and Full-Year Profitability Outlook - ChartMill
Journey Medical (NASDAQ: DERM) grows Q1 2026 revenue 21% but remains unprofitable - Stock Titan
Journey Medical Corporation Reports First Quarter 2026 Financial Results and Recent Corporate Highlights - The Manila Times
Journey Medical (Nasdaq: DERM) posts 21% Q1 2026 revenue growth - Stock Titan
Rosacea pill Emrosi powers Journey Medical’s 21% Q1 revenue jump - Stock Titan
0.15%
1.95%
大文字化:
|
ボリューム (24 時間):